Enteris BioPharma Inc.

As we enter the third year of the COVID-19 pandemic, the pharma industry has begun to adapt and grow around its constraints and opportunities. After the all-hands-on-deck scramble in early 2020, busin

“2021 will be a transformative year for biopharma and the life sciences. It will be the year where the credibility and power of science applied to human health will shine.” These words from Usman “Oz”

"The coming year will be remembered for the epic alteration to our society." These words from Pam Contag , CEO and co-founder of BioEclipse Therapeutics, Inc. , encapsulate the enormity of COVID-19'

More than 80 industry executives have shared with Scrip their expectations for the year ahead. In the third part of our preview series, we put the spotlight on the policy and regulatory environment.